175.86

2.68% 5.12

After Hours: 175.64 -0.22 -0.13%

Krystal Biotech Inc (KRYS)

Overview News Price History Option Chain Financials Why KRYS Down? Discussions Forecast

Krystal Biotech Inc stock is traded at $175.86, with a volume of 205.07K. It is up +2.68% in the last 24 hours and down -2.16% over the past month. Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Previous Close:

$170.74

Open:

$171.37

24h Volume:

205.07K

Relative Volume:

0.95

Market Cap:

$4.99B

Revenue:

$241.52M

Net Income/Loss:

$52.37M

P/E Ratio:

-119.63

EPS:

-1.47

Net Cash Flow:

$58.06M

1W Performance:

-10.49%

1M Performance:

-2.16%

6M Performance:

+6.83%

1Y Performance:

+68.31%

1-Day Range:

$168.88

$176.44

1-Week Range:

$168.88

$199.41

52-Week Range:

$99.00

$219.34

Krystal Biotech Inc Stock (KRYS) Company Profile

Name

Krystal Biotech Inc

Sector

Healthcare (1205)

Industry

Biotechnology (682)

Phone

(412) 586-5830

Address

2100 WHARTON STREET, PITTSBURGH, PA

Employee

229

Twitter

@KrystalBiotech

Next Earnings Date

2024-11-04

Latest SEC Filings

KRYS's Discussions on Twitter

Compare KRYS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KRYS	175.80	4.99B	241.52M	52.37M	58.06M	-1.47
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.83	24.42B	3.30B	-501.07M	1.03B	11.54

Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-20-23	Initiated	Goldman	Buy
Oct-24-23	Initiated	Cantor Fitzgerald	Overweight
Oct-12-23	Initiated	Citigroup	Buy
Sep-07-23	Initiated	Berenberg	Buy
Apr-18-23	Initiated	Stifel	Buy
Feb-28-23	Upgrade	Goldman	Neutral → Buy
Aug-25-22	Downgrade	Goldman	Buy → Neutral
Jan-18-22	Initiated	BofA Securities	Buy
Jul-20-21	Upgrade	Goldman	Neutral → Buy
Sep-18-20	Initiated	B. Riley FBR	Buy
Jun-04-20	Initiated	Evercore ISI	Outperform
Sep-24-19	Initiated	Goldman	Neutral
Aug-06-19	Reiterated	H.C. Wainwright	Buy
Jun-24-19	Reiterated	Chardan Capital Markets	Buy
Jun-24-19	Reiterated	H.C. Wainwright	Buy
May-30-19	Initiated	Guggenheim	Buy
Sep-11-18	Initiated	Cantor Fitzgerald	Overweight

View All

Krystal Biotech Inc Stock (KRYS) Latest News

Nov 15, 2024

Redmile Group, LLC Adjusts Stake in Krystal Biotech Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Principal Financial Group Inc. Sells 3,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Nov 14, 2024

Nov 13, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Nov 12, 2024

Nov 11, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Raised by TimesSquare Capital Management LLC - MarketBeat

Nov 11, 2024

Nov 09, 2024

Janney Montgomery Scott LLC Buys 5,415 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Nov 09, 2024

Nov 08, 2024

Chardan Capital Predicts Lower Earnings for Krystal Biotech - MarketBeat

Nov 08, 2024

Nov 07, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Simply Wall St

Nov 07, 2024

Q2 EPS Estimates for Krystal Biotech Raised by William Blair - MarketBeat

Nov 07, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Yahoo Finance

Nov 07, 2024

HC Wainwright Predicts Reduced Earnings for Krystal Biotech - MarketBeat

Nov 07, 2024

Nov 06, 2024

HC Wainwright Forecasts Higher Earnings for Krystal Biotech - MarketBeat

Nov 06, 2024

Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference - StockTitan

Nov 06, 2024

Krystal Biotech FY2024 EPS Forecast Raised by William Blair - MarketBeat

Nov 06, 2024

Nov 05, 2024

Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction - MSN

Nov 05, 2024

Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $206.00 at Citigroup - MarketBeat

Nov 05, 2024

Krystal Biotech (NASDAQ:KRYS) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 05, 2024

Krystal Biotech (NASDAQ:KRYS) Posts Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat

Nov 05, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 05, 2024

Krystal Biotech Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 05, 2024

Krystal stock gains modest boost from Citi, but compliance risks linger - Investing.com Canada

Nov 05, 2024